FDA NDC Directory · JSON-LD · Markdown
NDC 70710-1698 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Zydus Pharmaceuticals USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA090174 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (37.5 mg/1) |
| Marketing started | 20230518 |
| Package count | 5 |
Source: openFDA. Public-domain (CC0).